PRS Ready to Launch Global Regulatory Intelligence Database

Pharmaceutical Regulatory Services, Inc. a worldwide supplier of regulatory and pharmacovigilance support into the pharmaceutical, biotechnology and medical device industries is delighted to declare the launch of GRID™ - Global Regulatory Intelligence Database. According to our mission to provide our customers the foremost up-to-date global regulatory and pharmacovigilance support service all of us now offer an internet database of pre-approval and post-approval pharmacovigilance specifications for drugs and biologics in over 75 nations on all continents. The GRID™ presents an online reference resource by using original national legislative documentation for more in-depth research if needed.

Present on cloud technology platform, the database is developed and is kept by the PRS pharmacovigilance experts. The GRID™ database has information in an easy-to-find grid format along with hyperlinks to the most current quotation documents. As the database is checked by PRS, clients possess the capability to actually include their very own comments into a client specific remark section.

PRS safety specialists explore and collect applicable documentation. After reviewed and diagnosed details are entered into the GRID™, E-mail alert notifications are delivered to our clients, which includes summary of typical new information in English with hyperlinks to the unique referenced documentation. The GRID database is up-to-date daily as well as the clients' pharmacovigilance personnel can access the up-to-date information 24/7, 365 days a year.

Having access to this database's innovative technology and day-by-day updates of changes in worldwide pharmacovigilance requirements spares our client’s significant inside resources whereas ensuring all of their pharmacovigilance responsibilities might be met. The expansion of GRID attributes will still be a strategic focus for PRS in the future.